Global Mucus Clearance Devices Market to Exceed USD 847 Million by 2028, Driven by Rising Prevalence of Respiratory Conditions

The global mucus clearance devices market is poised for significant growth, with sales projected to surpass USD 847.0 million by 2028, according to a new report by Future Market Insights (FMI). The market, which was valued at USD 595.2 million in 2022, is expected to grow at a healthy compound annual growth rate (CAGR) of 6.1% during the forecast period.

This expansion is largely attributed to the increasing incidence of chronic respiratory conditions, particularly among the aging population. With more people suffering from ailments such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis, the demand for effective mucus clearance devices is on the rise. Furthermore, the growing number of specialized clinics, rehabilitation centers, ambulatory surgical centers, and hospitals is expected to fuel market growth in the coming years.

Government initiatives, especially in developing countries, aimed at raising awareness of treatment options for respiratory diseases, are also contributing to the market’s upward trajectory. These programs, coupled with favorable healthcare reimbursement policies and rising healthcare expenditure on advanced medical equipment, are expected to drive the adoption of lung mucus clearance devices.

“We are witnessing a paradigm shift in the management of respiratory conditions globally, with a growing emphasis on preventive and therapeutic interventions,” said FMI in the report. “As the prevalence of respiratory ailments continues to rise, the demand for effective mucus clearance devices is expected to surge, presenting lucrative opportunities for market players.”

The FMI report provides a comprehensive analysis of market drivers, challenges, and opportunities, along with detailed insights into the strategies of key players operating in the mucus clearance devices market.

Key Takeaways: Mucus Clearance Devices Market (2022-2028)

• The market is expected to reach USD 847.0 million by 2028, reflecting a steady growth of 6.1% CAGR (Compound Annual Growth Rate).
• This growth is driven by the increasing prevalence of respiratory diseases like COPD (Chronic Obstructive Pulmonary Disease), cystic fibrosis, and asthma.
• Developments in medical technology are leading to more effective and user-friendly mucus clearance devices.
• North America currently holds the largest market share (over 40%), followed by Europe and East Asia.
• The report highlights promising markets in developing economies like India, Brazil, and South Africa.
• Stringent regulations for medical device approval and lack of awareness about respiratory diseases in some regions are potential roadblocks.
• The majority of demand comes from home care settings, followed by hospitals.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!

Competition Landscape:

The global market for mucus clearance devices is dominated by well-established key players. Many of these companies are focusing on designing portable devices for mucus removal, aiming to enhance convenience for patients. Others are seeking to broaden their reach by entering emerging markets worldwide. Concurrently, some startups are dedicated to integrating advanced technology into these devices to offer more effective treatment options.

For instance:

• In January 2022, Life Wellness Healthcare, an Australian-based provider of respiratory medical devices, unveiled AirPhysio, its latest handheld Oscillating Positive Expiratory Pressure (OPEP) device. AirPhysio utilizes vibrations to loosen mucus and facilitate lung expansion, easing breathing. This drug-free device is specifically tailored to prevent severe symptoms in atelectasis patients.
• In December 2021, Respira Labs, a California-based medtech company, introduced Sylvee sensor, an adhesive patch worn on the lower rib cage. This innovative sensor monitors respiratory health by tracking trapped air in the lungs and lung air volume. Such data enables healthcare professionals to anticipate potential respiratory exacerbations in patients.

Key Companies Profiled:

• Hill-Rom Inc.
• Allergan
• Koninklijke Philips N.V.
• Respiratory Technologies, Inc.
• Smiths Medical
• Electromed, Inc.
• Monaghan Medical Corporation
• Thayer Medical
• VORTRAN Medical

Mucus Clearance Devices Market by Category:

Cycle Type:

• HFCWO Devices
• OPEP Devices
• MCA Devices
• IPV Devices
• PEP Devices

Indication:

• Cystic Fibrosis
• COPD
• Bronchiectasis
• Others

End User:

• Direct/Patient
• Hospitals
• Fertility Clinics & IVF Centers

Region:

• North America
• Latin America
• Europe
• Oceania
• East Asia
• South Asia
• Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube